Volition hosts kol roundtable on sepsis

Henderson, nev. , sept. 11, 2024 /prnewswire/ -- volitionrx limited (nyse american: vnrx) ("volition"), a multi-national epigenetics company, hosted a key opinion leader ("kol") roundtable in paris this weekend and brought together some of the world's leading experts in sepsis to explore the potential of using volition's nu.q® nets technology effectively in clinical practice.
VNRX Ratings Summary
VNRX Quant Ranking